Hi,
moomoo ID:NaN
Log Out
English
Back
Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Moomoo > Quotes > IQV IQVIA Holdings > Key Indicators
IQV IQVIA Holdings
218.085
+5.585+2.63%
YOY
Do not show
Hide blank lines
(Q3)2022/09/30(Q2)2022/06/30(Q1)2022/03/31(FY)2021/12/31
Financial Ratios
Efficiency Ratios TTM
Receivable Turnover(T)
6.02% 12.5171 2.23% 11.7457 20.82% 11.7628 23.98% 11.298
Fixed Assets Turnover(T)
11.93% 16.5495 12.17% 15.7154 16.55% 15.1955 25.50% 14.9504
Total Asset Rate(T)
4.85% 0.593 6.54% 0.5847 12.34% 0.5677 18.57% 0.5634
ROIC
39.35% 8.164% 57.31% 7.936% 83.66% 7.389% 107.68% 6.856%
ROE
60.99% 21.153% 95.21% 20.878% 155.44% 18.177% 245.11% 16.043%
ROA
52.88% 4.899% 86.24% 4.798% 153.72% 4.365% 236.13% 3.923%
FCF to Sales
-31.88% 11.917% -26.53% 11.948% -19.59% 13.646% 40.34% 16.592%
FCF to Net Income
-53.28% 144.247% -57.97% 145.603% -64.40% 177.479% -50.49% 238.302%
Efficiency Ratios
ROE 5 Year Average
-- -- -- -- -- -- 44.52% 8.565%
ROA 5 Year Average
-- -- -- -- -- -- 30.03% 2.605%
Average 5 Years ROIC
-- -- -- -- -- -- 22.62% 5.001%
Profitability Ratios TTM
Gross Margin
4.57% 34.724% 2.47% 34.416% 0.96% 33.991% -1.54% 33.451%
Operating Margin
45.67% 13.301% 39.02% 12.245% 44.44% 11.145% 47.75% 10.185%
Net Margin
45.80% 8.262% 74.82% 8.206% 125.85% 7.689% 183.47% 6.963%
EBITDA Margin
1.60% 0.2011% 4.76% 0.2025% 8.56% 0.2016% 9.12% 0.1994%
R & D Expense Ratio
-- 0.000% -- 0.000% -- 0.000% -- 0.000%
Sales Expense Ratio
-- 0.000% -- 0.000% -- 0.000% -- 0.000%
Administration Expense Rate
-- 0.000% -- 0.000% -- 0.000% -- 0.000%
Financial Health Ratios
Long-Term Debt to Equity Ratio
9.88% 233.813% 11.20% 241.031% 3.95% 217.216% -3.86% 204.353%
Total Assets to Common Equity
9.88% 453.020% 9.76% 456.147% 2.64% 421.845% -0.17% 408.623%
Debt to Asset Ratio
10.39% 236.637% 11.20% 243.871% 3.48% 218.736% -4.27% 205.859%
Current Ratio
-3.29% 0.9046 -8.51% 0.9622 -19.26% 0.9253 -18.62% 0.9088
Quick Ratio
-5.68% 0.7706 -5.92% 0.8309 -18.75% 0.8057 -18.65% 0.7796
GrowthRatios
Growth Ratios
Revenue CAGR(3Y)
-- -- -- -- -- -- 90.79% 10.041%
Revenue CAGR(5Y)
-- -- -- -- -- -- 2.94% 15.066%
Net Income CAGR(3Y)
-- -- -- -- -- -- 236.79% 55.081%
Net Income CAGR(5Y)
-- -- -- -- -- -- 936.27% 53.058%
FCF 1 Year Growth
-- -- -- -- -- -- 17.37% 71.407%
FCF CAGR(3Y)
-- -- -- -- -- -- 38.37% 42.532%
FCF CAGR(5Y)
-- -- -- -- -- -- -2.01% 27.028%
Currency Unit
USDUSDUSDUSD

FY: Financial Year Annual Report, which is equivalent to the 10-K file disclosed by the listed company to the SEC.

Q: Quarterly report, which is equivalent to the 10-Q file disclosed by the listed company to the SEC, where Q1, Q2, Q3, and Q4 are single quarterly reports with a span of 3 months; Q6 and Q9 are cumulative quarterly reports, and Q6 is 6 months , Q9 is 9 months.

The MOM data from the Quarterly report,MOM=(current period - last period)/last period *100%

Company Overview More
IQVIA Holdings, Inc. engages in the provision of analytics, technology solutions, and clinical research services to the life sciences industry. It operates through the following segments: Technology and Analytics Solutions, Research and Development Solutions, and Contract Sales and Medical Solutions. The Technology and Analytics Solutions segment supplies mission critical information, technology solutions and real-world solutions and services to the firm's life science clients. The Research and Development Solutions segment, which primarily serves biopharmaceutical customers, provides outsourced clinical research and clinical trial related services. The Contract Sales and Medical Solutions segment offers health care provider and patient engagement services to both biopharmaceutical customers and the broader healthcare market. The company was founded by Dennis B. Gillings and Gary Koch in 1982 and is headquartered in Durham, NC.
CEO: Mr. Ari Bousbib
Market: NYSE
Listing Date: 05/09/2013
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...

Watchlist